Elevation Oncology
Genomic Testing Cooperative to ID Patients for Elevation Oncology's Seribantumab Trial
GTC will use its Solid Tumor Profile Plus test to identify solid cancer patients with NRG1 gene fusions for enrollment in Elevation's Phase II CRESTONE trial.
Caris Life Sciences, Elevation Oncology Team on Targeted Drug Development
The companies are working together to mine Caris' multiomic data for new cancer drug targets, sharing drug/diagnostic development costs for chosen candidates.